RNU6-709P

Across TCGA pan-cancer cohorts, RNU6-709P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-709P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-709P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-709P expression acts as an unfavorable survival marker.

STAD, ACC, and KIRP are the cancer types where RNU6-709P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	IV	0.083	0.379	.001	36	view →
ACC	OS	Tertile	All	0.268	0.802	.010	36	view →
KIRP	DFS	Tertile	IV	0.088	0.502	<.001	36	view →
LAML	DFS	Tertile	All	0.152	0.578	.016	18	view →
LIHC	OS	Tertile	All	0.188	0.669	.041	18	view →
PCPG	DFS	Tertile	All	0.070	0.936	<.001	18	view →
SKCM	DFS	Tertile	All	0.182	0.739	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU6-709P–STAD (DFS)

Open the STAD breakdown →